Expert Perspectives: Advances in the Treatment of Metastatic Breast Cancer

The treatment of hormone receptor positive/HER2 negative metastatic breast cancer remains challenging. Review answers to some of the most important questions posed by your oncology peers from a series of live Tumor Boards this year.

Next steps

  • Register or login and click the Start button
  • Complete course evaluation
  • Download Certificate
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 CA-BRN
  • 1.00 ANCC
Course opens: 
07/21/2016
Course expires: 
07/20/2017
Cost:
$0.00
Rating: 
4

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 CA-BRN
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.